These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20340104)
21. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site. Virtanen SI; Pentikäinen OT J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004 [TBL] [Abstract][Full Text] [Related]
22. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening. Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193 [TBL] [Abstract][Full Text] [Related]
23. Docking and scoring in virtual screening for drug discovery: methods and applications. Kitchen DB; Decornez H; Furr JR; Bajorath J Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816 [TBL] [Abstract][Full Text] [Related]
24. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510 [TBL] [Abstract][Full Text] [Related]
25. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application. Baroni M; Cruciani G; Sciabola S; Perruccio F; Mason JS J Chem Inf Model; 2007; 47(2):279-94. PubMed ID: 17381166 [TBL] [Abstract][Full Text] [Related]
26. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase. Luzhkov VB; Selisko B; Nordqvist A; Peyrane F; Decroly E; Alvarez K; Karlen A; Canard B; Qvist J Bioorg Med Chem; 2007 Dec; 15(24):7795-802. PubMed ID: 17888664 [TBL] [Abstract][Full Text] [Related]
27. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy. Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350 [TBL] [Abstract][Full Text] [Related]
28. Optimization of the MAD algorithm for virtual screening. Eckert H; Bajorath J Methods Mol Biol; 2008; 453():349-62. PubMed ID: 18712313 [TBL] [Abstract][Full Text] [Related]
29. In-silico drug screening method based on the protein-compound affinity matrix using the factor selection technique. Murali S; Hojo S; Tsujishita H; Nakamura H; Fukunishi Y Eur J Med Chem; 2007 Jul; 42(7):966-76. PubMed ID: 17307278 [TBL] [Abstract][Full Text] [Related]
31. The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches. Pirard B; Brendel J; Peukert S J Chem Inf Model; 2005; 45(2):477-85. PubMed ID: 15807513 [TBL] [Abstract][Full Text] [Related]
32. Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution. Yamazaki K; Kusunose N; Fujita K; Sato H; Asano S; Dan A; Kanaoka M Bioorg Med Chem Lett; 2006 Mar; 16(5):1371-9. PubMed ID: 16337379 [TBL] [Abstract][Full Text] [Related]
33. A novel search engine for virtual screening of very large databases. Vidal D; Thormann M; Pons M J Chem Inf Model; 2006; 46(2):836-43. PubMed ID: 16563015 [TBL] [Abstract][Full Text] [Related]
34. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening. Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515 [TBL] [Abstract][Full Text] [Related]
35. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition. Wei NN; Hamza A J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054 [TBL] [Abstract][Full Text] [Related]